Hailing the benefits of 15 years of biosimilar prescribing in Europe, The Biosimilar Medicines Group has called on the European Medicines Agency to take stronge 25 January 2022
The latest safety data from the European Medicines Agency provides reassurance on the use of mRNA vaccines for COVID-19 during pregnancy. 19 January 2022
Vertex Pharmaceuticals has successfully broadened the label for Kaftrio (ivacaftor/tezacaftor/elexacaftor) in Europe, to include treatment of cystic fibrosis (C 11 January 2022
The European Commission (EC) has granted US biotech Novavax conditional marketing authorization (CMA) for its Nuvaxovid COVID-19 Vaccine (recombinant, adjuvante 21 December 2021
In August 2020, Russia approved its homegrown coronavirus vaccine Sputnik V, months ahead of rival programs in the west. Episode 8 of The Pharma Letter Podcast 14 December 2021
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.